Publications by Li-Cai Mo

Publications by authors named "Li-Cai Mo"

Front Oncol

November 2022

The study focuses on improving predictions of clinically significant prostate cancer (csPCa) using multiparametric MRI (mpMRI) and the Prostate Health Index (PHI) in a group of 315 men scheduled for prostate biopsies.
A nomogram was developed based on a multivariate model that combined PHI, mpMRI assessments (using PI-RADS V2), free PSA (fPSA), and prostate volume to enhance prediction accuracy.
The results indicated that the proposed model significantly outperforms traditional methods, reducing unnecessary biopsies while effectively identifying csPCa.*

Hum Vaccin Immunother

December 2022

- The study investigated how health behaviors correlated with COVID-19 vaccination among healthcare workers in Taizhou, China, using an online survey conducted in May 2021.
- Out of 660 staff members, 592 responded, with findings indicating no major differences in health behaviors pre and post-vaccination, except for glove usage, which was higher among vaccinated individuals.
- Interestingly, those vaccinated earlier reported improved health behaviors, showing increased mask-wearing, handwashing, and glove use after vaccination, suggesting that risk compensation did not occur in this group.

Urol Int

April 2022

The study investigates the expression of inhibin βE (INHBE) in clear-cell renal cell carcinoma (ccRCC) patients to determine its role in cancer progression.
Researchers analyzed RNA sequencing data and conducted immunohistochemistry on tumor samples, finding increased levels of INHBE mRNA and protein in cancer tissues compared to normal samples.
The findings suggest that higher inhibin βE levels are associated with worse tumor grades and shorter survival rates, indicating its potential role as a tumor promoter in ccRCC.

World J Clin Cases

June 2021

Pelvic lipomatosis (PL) is a rare condition characterized by abnormal fat growth that compresses pelvic organs, often causing lower urinary tract symptoms (LUTS) and is associated with cystitis glandularis (CG).
A patient with PL and CG was treated with a procedure called transurethral resection of bladder tumor (TUR-BT) and oral celecoxib, which relieved LUTS and improved bladder examination results.
This case suggests that celecoxib, a COX-2 inhibitor, might be an effective treatment option for PL in combination with refractory CG, highlighting the potential role of COX-2 in this condition.